Ora’s reputation has been built upon a solid foundation of scientific rigor and research excellence.
Since our founding, we have developed a series of proprietary clinical models that have consistently generated accurate and reliable data to support regulatory approvals, both in the US and around the world.
We design, execute, and innovate the most efficient ophthalmic clinical development programs in the industry. Through our internal R&D efforts at the Ora Institute, we dedicate considerable resources towards internal research and development to advance ophthalmic clinical research design, including model innovation and evolution, endpoint development and evaluation, and clinical trial processes and management strategies.
We have earned a reputation for pioneering new clinical pathways, developing and applying new technology and creating significant value for our clients. We have extensive drug development experience in the areas of dry eye, allergy, glaucoma, anti-infective, anti-inflammatory and retinal ophthalmic treatments.